¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"autonomic part of peripheral nervous system"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • somatosensory system
    ¸ö°¨°¢°èÅë
  • sound conduction system
    ¼Ò¸®Àü´Þ°èÅë, ÀüÀ½°è
  • static system
    Á¤Áö°è
  • stereotactic system
    Á¤À§°íÁ¤±â
  • subcortical descending system
    °ÑÁú¹ØÇÏÇà°è, °ÑÁú¹Ø³»¸²°èÅë
  • superficial musculo-aponeurotic system
    ¾ó±¼³ÎÈûÁÙ°èÅë
  • to and fro absorbent system
    ¿Õº¹Èí¼ö½Äȸ·Î
  • transdermal drug delivery system
    °æÇǾ๰Àü´Þü°è
  • urinary system
    ºñ´¢°èÅë
  • urogenital system
    ºñ´¢»ý½Ä°èÅë
  • value system
    °¡Ä¡Ã¼°è
  • vascular system
    Ç÷°ü°èÅë
  • workload recording system
    ÀÛ¾÷ºÎÇϱâ·Ïü°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • renal collecting system
    ½ÅÁýÇÕ°ü°èÅë
  • renal depressor system
    ½Å°­¾Ð°è.
  • renal pressor system
    ½Å½Â¾Ð°è(¡­ã°äâͧ).
  • renin angiotensin system
    ·¹´Ñ¾ÈÁö¿ÀÅٽŰè(¡­Í§).
  • renin-angiotensin system
    ·¹´Ñ¾ÈÁö¿ÀÅÙ½Åü°è
  • renin-angiotensin system
    ·¹´Ñ-¾ÈÁö¿ÀÅٽŰè(¡­Ìõ)
  • renin-angiotensin-aldosterone system
    ·¹´Ñ-¾ÈÁö¿ÀÅÙ½Å-¾Ëµµ½ºÅ×·Ðü°è
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • peripheral uveitis
    ÁÖº¯Æ÷µµ¸·¿°
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üÁúȯ(¡­Ç÷°üÁúȯ).
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üÁúȯ(ØÇôþúìηòðü´)
  • peripheral vascular resistance
    ¸»ÃÊÇ÷°ü ÀúÇ×.
  • peripheral vasodilation
    ¸»ÃÊÇ÷°üÈ®Àå.
  • peripheral vertigo
    ¸»ÃÊ(¼º) ¾îÁö·³, ¸»ÃÊ(¼º) Çö±â
  • peripheral vertigo
    ¸»Ãʼº ¾îÁö·³, ¸»Ãʼº Çö±â.
  • peripheral vision
    ÁÖº¯½Ã(ñ²Ü«ãÊ).
  • peripheral visual field
    ÁÖº¯½Ã¾ß(ñ²Ü«ãÊå¯).
  • peripheral vocal cord paralysis
    ¸»ÃÊ(¼º) ¼º´ë¸¶ºñ
  • peripheral zone
    ¸»ÃÊ´ë
  • peripheral zone
    ¼ÒÀý°ü(á³ï½Î·).
  • peripheral zone
    ÁÖº¯±¸¿ª
  • pulmonary cyst,peripheral
    ¸»Ãʼº(ØÇôþàõ)
  • total peripheral resistance
    Àü<ÃÑ>¸»ÃÊÀúÇ×(îï<õÅ>ØÇôþî½ù÷)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • Horizontal part
    ¾Æ·¡[¼öÆò]ºÎºÐ
    [¿¾ ¿ë¾î] ¼öÆòºÎ
  • Hepatic part of inferior vena cava
    ¾Æ·¡´ëÁ¤¸Æ°£ºÎºÐ
    [¿¾ ¿ë¾î] ÇÏ´ëÁ¤¸Æ°£ºÎ
  • Inferior part
    ¾Æ·¡ºÎºÐ
    [¿¾ ¿ë¾î] ÇϺÎ
  • Mylopharyngeal part
    ¾Æ·¡ÅÎÀεκκÐ
    [¿¾ ¿ë¾î] ¾ÇÀεκÎ
  • Intraocular part
    ¾È±¸ºÎºÐ
    [¿¾ ¿ë¾î] ¾È±¸³»ºÎ
  • Medial part
    ¾ÈÂʺκÐ
    [¿¾ ¿ë¾î] ³»ÃøºÎ
  • Medial (part of) globus pallidus
    ¾ÈÂÊâ¹éÇÙ
    [¿¾ ¿ë¾î] ³»Ãø´ãⱸ
  • Anterior part
    ¾ÕºÎºÐ
    [¿¾ ¿ë¾î] ÀüºÎ
  • Anterior part
    ¾ÕºÎºÐ
    [¿¾ ¿ë¾î] ÀüÁÖ
  • Anterior part [Crus cerebri]
    ¾ÕºÎºÐ [´ë³ú¼¶À¯´Ù¸®]
    [¿¾ ¿ë¾î] ÀüºÎ
  • Anterior tibiotalar part
    ¾ÕÁ¤°­¸ñ¸»ºÎºÐ
    [¿¾ ¿ë¾î] Á¤°æ°ÅºÎ
  • Superficial part
    ¾èÀººÎºÐ
    [¿¾ ¿ë¾î] õºÎ
  • Cartilaginous part
    ¿¬°ñºÎºÐ
    [¿¾ ¿ë¾î] À̰ü¿¬°ñºÎ
  • Cartilagneous part
    ¿¬°ñºÎºÐ
    [¿¾ ¿ë¾î] ¿¬°ñºÎ
  • Intercartilagenous part
    ¿¬°ñ»çÀ̺κÐ
    [¿¾ ¿ë¾î] ¿¬°ñ°£ºÎ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
RAS rapid atrial stimulation; recurrent aphthous stomatitis; reflex activating stimulus; reliability, av...
SCS Saethre-Chotzen syndrome; shared computer system; silicon-controlled switch; Society of Clinical Sur...
SIS semantic indexing system; serotinin irritation syndrome; simian sarcoma; simulator-induced syndrome;...
SMAS submuscular aponeurotic system; superficial musculo-aponeurotic system; superior mesenteric artery s...
PAS   1) Periodic Acid-Schiff Stain
  2) Para-Amino-Salicyclic Acid
 &nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
PBL Peripheral blood
PBMC Peripheral blood
PBC Peripheral blood cell
PBL Peripheral blood leucocyte
PBMC Peripheral blood lymphocytes
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dynamic system
    µ¿Àû °èÅë
  • ectopic system
    »ýŰè
    ¾î¶² Áö¿ªÀÇ »ý¹° °øµ¿Ã¼¿Í À̰ÍÀ» À¯ÁöÇϰí ÀÖ´Â ¹«±âÀû ȯ°æÀÌ Á¾ÇÕµÈ ¹°Áú°è ¶Ç´Â ±â´É°è. »ýŰè¶õ ¿µ±¹ÀÇ A.G. ÅĽ½¸®¿¡ ÀÇÇÏ¿© 1935³â Á¦Ã¢µÈ ¿ë¾î·Î, ÀÚ¿¬ÀÇ ÀÖ´Â ±×´ë·ÎÀÇ »óŸ¦ ÀνÄÇϱâ À§Çؼ­´Â ÀÌ°Íµé »óÈ£°£ÀÇ °ü°è¸¦ Áö´Ñ »ý¹°°ú ¹«±âÀû ȯ°æÀ» Çϳª·Î ÅëÇÕÇØ¾ß ÇÑ´Ù´Â °ÍÀÌ ÅĽ½¸®°¡ Á¦Ã¢ÇÑ °³³äÀÌ´Ù. Áö±¸ »ýŰè´Â ±× ³ÐÀÌ¿¡¼­´Â »ý¹°±Ç°ú ÀÏÄ¡ÇÑ´Ù. ¹«±âÀû ȯ°æÀÇ Æ¯Â¡¿¡ ÀǰÅÇÏ¿© ÇØ¾ç »ýŰè, È£¼Ò »ýŰè, ±ØÁö »ýŰè, »ç¸· »ýÅÂ°è µîÀ¸·Î ±¸º°Çϰí, ¶Ç ±º¶ôÀÇ »ó°ü¿¡ µû¶ó¼­ »ï¸² »ýŰè, ÃÊÁö »ýÅÂ°è µîÀ¸·Î ±¸ºÐÇϱ⵵ ÇÑ´Ù. ¶ÇÇÑ, °æÁö »ýŰè, µµ½Ã »ýŰè¿Í °°Àº °Íµµ »ý°¢ÇÒ ¼ö ÀÖ´Ù. »ýŰè Áß¿¡¼­ »ý¹°Ã¼´Â ±â´ÉÀûÀ¸·Î »ý»êÀÚ
  • endocrine system
    ³»ºÐºñ°è
    ÀÎüÀÇ Á¶Àý ±â´ÉÀ¸·Î ¼¼Æ÷°£ÀÇ ´ëÈ­¸¦ È­ÇÐ ¹°ÁúÀΠȣ¸£¸óÀ» ÅëÇØ¼­ È­ÇÐÀûÀÎ ½ÅÈ£¸¦ ÀÌ¿ëÇÏ¿© Ç¥Àû ¼¼Æ÷µé¿¡ ÀÛ¿ëÇÑ´Ù. ÈçÇÑ ³»ºÐºñ°è ÀÌ»óÀº ºñÁ¤»óÀûÀÎ ¼ºÀå, ¿¡³ÊÁö ¼öÁØ º¯È­ ¿Âµµ º¯È­¿¡ÀÇ ºÎÀûÀÀ ¹× ¼³¸íµÇÁö ¾Ê´Â üÁß º¯È­·Î ³ªÅ¸³­´Ù. ´Ù´¢, °úµµÇÑ °¥Áõ, üÁß °¨¼Ò¸¦ µ¿¹ÝÇÑ ½Ä¿å °ú´Ù´Â ´ç´¢º´ÀÇ Æ¯Â¡ÀÌ´Ù. ½Ã·Â º¯È­, ½ÅÀå ±â´ÉÀå¾Ö, »çÁöÀÇ Ç÷¾× ¼øÈ¯ °¨¼Ò´Â Àå±â°£ÀÇ ´ç´¢·Î ÀÎÇÑ ÁøÇàµÈ Ç÷°ü °æÈ­ÀÇ Áõ»óÀÌ´Ù.
  • endogenous analgesic peptide system
    ³»¿ø¼º ÁøÅ뼺 ÆéƼµå°è
  • epidermal system
    Ç¥Çǰè
  • excretory system
    ¹è¼³°è
  • extrapyrarnidal system
    Ãßü¿Ü·Î°è
  • fiber optic delivery system
    ±¤ ¼¶À¯ Àü´Þ°è
  • fingerprint system
    Áö¹®°è
  • fusimotor system
    ¹æÃß ¿îµ¿°è
  • human system
    ÀÎü°è
  • hypophyseal portal system
    ³úÇϼöü ¹®¸Æ °èÅë, Çϼöü ¹®¸Æ°è
  • hypothalamohypophyseal system
    ½Ã»ó ÇϺΠ³úÇϼöü°è
  • hypothalamopituitary system
    ½Ã»ó ÇϺΠ³úÇϼöü°è
  • hypothalamus pituaitary system
    ½Ã»ó ÇϺΠ³úÇϼöü°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
point system test types A near-vision test chart in which the various test types are multiples of a point (1/72 inch), lower-case letters being one-half the designated point size; reading 4-point at 16 inches is normal, and is designated N-4.
(05 Mar 2000)
craniosacral system parasympathetic part
portal system A system of vessels in which blood, after passing through one capillary bed, is conveyed through a second set of capillaries before it returns to the systemic circulation. It pertains especially to the hepatic portal system.
(12 Dec 1998)
haematopoietic system The blood-making organs; in the embryo at different ages these are the yolk sac, liver, thymus, spleen, lymph nodes, and bone marrow; after birth they are principally the bone marrow, spleen, thymus, and lymph nodes.
(05 Mar 2000)
haemolytic system <haematology> A haemolytic system is composed of red blood cells covered with antibodies which are genetically identical to the surface proteins (antigens) of the red blood cells.
It is used to measure how much complement is left after a round of complement fixation.
(09 Oct 1997)
cytochrome system The mitochondrial electron transport chain.
(18 Nov 1997)
pressoreceptor system The pressoreceptive areas which with their afferent fibres and connections with the autonomic system react to a rise in arterial blood pressure and serve to buffer it by inhibiting the heart rate and vascular tone.
See: baroreceptor.
(05 Mar 2000)
haversian system <anatomy> The basic unit of structure of compact bone, comprising a haversian canal and its concentrically arranged lamellae, of which there may be 4 to 20, each 3 to 7 microns thick, in a single haversian system.
A haversian canal is a freely anastomosing channel in compact bone containing blood vessels and running longitudinally in the centre of haversian systems of compact osseous tissue.
It was originally described by Clopton Havers, an english physician, in 1691.
(12 Dec 1998)
heart conduction system An impulse-conducting system composed of modified cardiac muscle and having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart.
(12 Dec 1998)
projection system The system of axons carrying stimuli from one portion of the nervous system to other portions.
(05 Mar 2000)
hepatic portal system A venous portal system in which the portal vein receives blood via its tributaries from the capillaries of most of the abdominal viscera and drains it into the hepatic sinusoids.
(05 Mar 2000)
properdin system An immunological system that is the alternative pathway for complement, composed of several distinct proteins that react in a serial manner and activate C3 (third component of complement), seemingly without utilizing components C1, C4, and C2; in addition to properdin, the system includes properdin factors A (native C3), B (C3 proactivator), D (C3 proactivator convertase), and perhaps at least one other, E; the system can be activated, in the absence of specific antibody, by bacterial endotoxins, by a variety of polysaccharides and lipopolysaccharides, and by a component of cobra venom.
(05 Mar 2000)
prospective payment system A system wherein reimbursement rates are set, for a given period of time, prior to the circumstances giving rise to actual reimbursement claims.
(12 Dec 1998)
Schlieren system <microscopy> A system for enhancing path length differences, refractive index differences in transparent media, or height differences for light reflected from surfaces.
(05 Aug 1998)
heterogeneous system In chemistry, a system that contains various distinct and mechanically separable parts or phases; e.g., a suspension or an emulsion.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á